Cargando…
Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
High level of tumor-infiltrating lymphocytes (TILs) can predict the rate of total pathological complete remission (tpCR) of breast cancer patients who receive neoadjuvant chemotherapy (NACT). This study focused on evaluating the data of patients whose primary tumor and/or lymph node metastasis show...
Autores principales: | Qian, Xiao-Long, Xia, Xiao-Qing, Li, Ya-Qing, Jia, Yu-Mian, Sun, Yuan-Yuan, Song, Yuan-Ming, Xue, Hui-Qin, Hao, Yan-Fei, Wang, Jin, Wang, Xiao-Zi, Liu, Chen-Ying, Zhang, Xin-Min, Zhang, Li-Na, Guo, Xiao-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247751/ https://www.ncbi.nlm.nih.gov/pubmed/37286786 http://dx.doi.org/10.1038/s41598-023-36517-2 |
Ejemplares similares
-
Neoadjuvant chemotherapy for locally invasive cervical cancer in pregnancy: two case reports
por: Li, Ming-Zhu, et al.
Publicado: (2019) -
Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer
por: Feng, Wen, et al.
Publicado: (2016) -
The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
por: Mao, Yan, et al.
Publicado: (2014) -
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016) -
A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2018)